Aetna did not cover the service because it was considered “experimental/investigational” and “not identified as widely used and generally accepted for the proposed uses as reported in nationally recognized peer-reviewed medical literature,” according to a June 27 blog post from ASNC.
In the letter, the two medical groups urged the payer to reverse the policy because its policy was not aligned with current U.S. standards and practice of cardiac PET/CT scans.